← Open Payments lookup

RASHIDAT LAIYEMO: Open Payments

NPI 1144825613 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$333 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $333

Food & beverage: $333
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation4$100
GENZYME CORPORATION2$69
Regeneron Healthcare Solutions, Inc.2$55
BioCryst US Sales Co., LLC2$42
Ionis Pharmaceuticals, Inc.1$28
ARS Pharmaceuticals Operations, Inc.1$27
AstraZeneca Pharmaceuticals LP1$14

Products named: DUPIXENT, Rhapsido, ORLADEYO, DAWNZERA, NEFFY, FASENRA.

Industry payments across MD — which companies pay providers there.